Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 193 publications
Telehealth and Electronic Messages in Hematology: The Good, the Bad, and the Ugly.
Journal: JCO oncology practice
Published: August 31, 2026
Sequenced, Not Stirred: Positioning CAR T and Bispecific Antibody Therapy in Multiple Myeloma.
Journal: Blood cancer discovery
Published: August 01, 2026
36 is the new 18: Functional high-risk multiple myeloma in the modern era.
Journal: Cancer
Published: July 24, 2026
Machine Learning for Monoclonal Gammopathy of Undetermined Significance Screening: Who, How, and Why?
Journal: JCO clinical cancer informatics
Published: June 22, 2026
Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.
Journal: The New England journal of medicine
Published: June 15, 2026
BRIDGE-2M: Optimizing Bridging Therapy Prior to CAR-T Therapy in Multiple Myeloma: A Modified Double-Blind Delphi Panel of US Physicians.
Journal: Advances in therapy
Published: June 01, 2026
Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 20, 2026
Real-world treatment patterns and outcomes of patients with multiple myeloma initiating elranatamab: results from the ALTITUDE-1 and ALTITUDE-2 retrospective cohort studies.
Journal: Future oncology (London, England)
Published: April 23, 2026
Real-world outcomes with BCMA- and GPRC5D-targeting bispecific antibodies in plasma cell leukemia.
Journal: Blood advances
Published: April 21, 2026
Real-World Outcomes with BCMA- and GPRC5D-Targeting Bispecific Antibodies in Plasma Cell Leukemia.
Journal: Blood advances
Published: April 21, 2026
Withstanding the test of time for patients in oncology clinical trials.
Journal: The oncologist
Published: April 05, 2026
Last Updated: 09/26/2026